Nanozyme-strip for rapid local diagnosis of Ebola

Audet, 2014, Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus, Sci. Rep., 4, 6881, 10.1038/srep06881 Bishop, 2015, Potential and emerging treatment options for Ebola virus disease, Ann. Pharmacother., 49, 196, 10.1177/1060028014561227 Boumandouki, 2005, Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo, Bull. Soc. Pathol. Exot., 98, 218 Butler, 2014, Ebola experts seek to expand testing, Nature, 516, 154, 10.1038/516154a Cho, 2010, Immunogold-silver staining-on-a-chip biosensor based on cross-flow chromatography's, J. Chromatogr. B, 878, 271, 10.1016/j.jchromb.2009.07.016 Daaboul, 2014, Digital sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: a model for ebola and marburg detection, ACS Nano, 8, 6047, 10.1021/nn501312q Fan, 2012, Magnetoferritin nanoparticles for targeting and visualizing tumour tissues, Nat. Nanotechnol., 7, 459, 10.1038/nnano.2012.90 Gao, 2013, Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus, J. Virol., 87, 13134, 10.1128/JVI.02433-13 Gao, 2007, Intrinsic peroxidase-like activity of ferromagnetic nanoparticles, Nat. Nanotechnol., 2, 577, 10.1038/nnano.2007.260 Gao, 2014, Recent advances in nanoparticles-based Lateral flow biosensors, Am. J. Biomed. Sci., 6, 41, 10.5099/aj140100041 Han, 2007, Plastic enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor for botulinum neurotoxin A, Anal. Chim. Acta., 587, 1, 10.1016/j.aca.2007.01.028 Huang, 2009, General strategy for designing functionalized magnetic microspheres for different bioapplications, Langmuir, 25, 11657, 10.1021/la901258p Jin, 2014, JAMA patient page. Ebola virus disease, J. Am. Med. Assoc., 312, 1942, 10.1001/jama.2014.13759 Ksiazek, 1992, Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates, J. Clin. Microbiol., 30, 947, 10.1128/JCM.30.4.947-950.1992 Li, 2005, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies, J. Virol., 79, 10108, 10.1128/JVI.79.16.10108-10125.2005 Liang, 2013, Fe3O4 magnetic nanoparticle peroxidase mimetic-based colorimetric assay for the rapid detection of organophosphorus pesticide and nerve agent, Anal. Chem., 85, 308, 10.1021/ac302781r Lucht, 2007, Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection, J. Infect. Dis., 196, S184, 10.1086/520593 Mirasoli, 2012, Development of a chemiluminescence-based quantitative lateral flow immunoassay for on-field detection of 2,4,6-trinitrotoluene, Anal. Chim. Acta., 721, 167, 10.1016/j.aca.2012.01.036 Mirasoli, 2012, Chemiluminescence-based biosensor for fumonisins quantitative detection in maize samples, Biosens. Bioelectron., 32, 283, 10.1016/j.bios.2011.11.039 Paragas, 2006, Development of treatment strategies to combat Ebola and Marburg viruses, Expert Rev. Anti Infect. Ther., 4, 67, 10.1586/14787210.4.1.67 Parolo, 2013, Enhanced lateral flow immunoassay using gold nanoparticles loaded with enzymes, Biosens. Bioelectron., 40, 412, 10.1016/j.bios.2012.06.049 Posthuma-Trumpie, 2009, Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey, Anal. Bioanal. Chem., 393, 569, 10.1007/s00216-008-2287-2 Qiu, 2011, Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies, Clin. Immunol., 141, 218, 10.1016/j.clim.2011.08.008 Qiu, 2012, Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies, Sci. Transl. Med., 4, 10.1126/scitranslmed.3003876 Qiu, 2014, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp, Nature, 514, 47, 10.1038/nature13777 Sanchez, 1999, Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates, J. Infect. Dis., 179, S164, 10.1086/514282 Shyu, 2002, Colloidal gold-based immunochromatographic assay for detection of ricin, Toxicon, 40, 255, 10.1016/S0041-0101(01)00193-3 Smith, 2011, Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays, Anal. Biochem., 410, 124, 10.1016/j.ab.2010.11.005 Song, 2012, DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza, Mol. Ther., 20, 1472, 10.1038/mt.2012.69 Srinivasan, 2009, A detection system based on giant magnetoresistive sensors and high-moment magnetic nanoparticles demonstrates zeptomole sensitivity: potential for personalized medicine, Angew. Chem. Int. Ed. Engl., 48, 2764, 10.1002/anie.200806266 Towner, 2004, Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome, J. Virol., 78, 4330, 10.1128/JVI.78.8.4330-4341.2004 Vogel, 2014, Infectious Diseases. Testing new Ebola tests, Science, 345, 1549, 10.1126/science.345.6204.1549 Wang, 2011, Magnetic nanoparticle-enhanced biosensor based on grating-coupled surface plasmon resonance, Anal. Chem., 83, 6202, 10.1021/ac200751s Wei, 2013, Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes, Chem. Soc. Rev., 42, 6060, 10.1039/c3cs35486e WHO, 2015a. Ebola Situation Report. 〈http://www.who.int/csr/disease/ebola/situation-reports/en/〉. Accessed (14.04.2015). WHO, 2015b. First Antigen Rapid Test for Ebola through Emergency Assessment and Eligible for Procurement. 〈http://www.who.int/medicines/ebola-treatment/1st_antigen_RT_Ebola/en/〉. Accessed (14.04.2015). Yang, 2009, A practical glucose biosensor based on Fe(3)O(4) nanoparticles and chitosan/nafion composite film, Biosens. Bioelectron., 25, 889, 10.1016/j.bios.2009.09.002 Yang, 2011, A colloidal gold probe-based silver enhancement immunochromatographic assay for the rapid detection of abrin-a, Biosens. Bioelectron., 26, 3710, 10.1016/j.bios.2011.02.016 Yang, 2000, Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury, Nat. Med., 6, 886, 10.1038/78654 Yen, 2015, Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses, Lab Chip, 15, 1638, 10.1039/C5LC00055F Yu, 2012, Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies, PLoS One, 7, e38291, 10.1371/journal.pone.0038291 Yu, 2011, Fever with thrombocytopenia associated with a novel bunyavirus in China, N. Engl. J. Med., 364, 1523, 10.1056/NEJMoa1010095 Zhang, 2010, Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus, Protein Cell, 1, 459, 10.1007/s13238-010-0059-1 Zhuang, 2012, Ex vivo detection of iron oxide magnetic nanoparticles in mice using their intrinsic peroxidase-mimicking activity, Mol. Pharm., 9, 1983, 10.1021/mp300033a